ByHeart
PrivateLast Round
Series C
Mar 27, 2025
Est. Valuation
$908M
Total Funding Raised
$380.55M
Company Overview
ByHeart operates in Consumer & Commerce and is based in New York City, New York. Its latest recorded funding round was a Series C round in March 2025.
ByHeart is a food products company that provides infant nutrition formula intended to offer nutritious food for babies.
Sector
Consumer & Commerce
Verticals
D2C Brands, E-commerce, Home & Lifestyle
Business Model
B2C
Customer Profile
Subscription SaaS
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ByHeart Comparables
Compare ByHeart with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Bobbie | 90% | |
| Kendal Nutricare Ltd | 86% | |
| Nara Organics | 84% |
For institutional investors. Book with your work email.
ByHeart Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Mar 27, 2025 | ||||
| Series B | Mar 12, 2025 | ||||
| Series C | May 13, 2024 | ||||
| Early Funding | Jan 13, 2023 | ||||
| Grant | Dec 6, 2021 | ||||
Series B | Jul 26, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
ByHeart Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Two River Group | Series A, Series C, Seed, Series B |
| S.q.p | Series B |
| Red Sea Ventures | Series A, Series C, Series B |
| AF Ventures | Series C, Series B |
| Gaingels | Series C, Series B |
| Sonostar Ventures | Series C |
| Bellco Capital | Series A, Series C, Series B, Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 19, 2026
Partnered with Baby2Baby to provide essentials to children in need.
- Nov 24, 2025
Partnered with IEH Laboratories for product testing amid recall.
For institutional investors. Book with your work email.
ByHeart Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about ByHeart's valuation, stock price, and market status.
Is ByHeart a public or private company?
ByHeart is a private company.
What is the current stock price of ByHeart?
ByHeart is a private company, so its shares have no public market price. Caplight tracks ByHeart's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ByHeart worth (valuation)?
ByHeart's valuation is estimated at $908.0M based on funding round data.
Can I buy ByHeart stock?
ByHeart shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ByHeart's last funding round?
ByHeart's most recent funding round was Series C on March 27, 2025.
Who are the main investors in ByHeart?
Key investors in ByHeart include Two River Group, Gaingels, D1 Capital Partners, Polaris Partners, OCV Partners.
Will ByHeart IPO soon?
No public IPO plans have been announced for ByHeart.
How can I track ByHeart secondary market activity?
Caplight tracks bids, offers, and trades in ByHeart's shares on secondary markets.